Hamza Suria, former AnaptysBio CEO
AnaptysBio CEO abruptly resigns less than a week after mid-stage flop
Less than a week after AnaptysBio dropped another indication for its lead drug, the biotech’s longtime CEO has decided to tap out.
Hamza Suria tendered …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
